Advent Capital Management’s Merck MRK Stock Holding History

Advent Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,000	Closed	-$2.49M	–	227
2024 Q4	$2.49M	Buy	25,000 +20,000	+400%	+$2.06M	0.06%	148
2024 Q3	$568K	Buy	+5,000	New	+$594K	0.01%	196
2023 Q4	–	Sell	-30,000	Closed	-$3.09M	–	202
2023 Q3	$3.09M	Buy	+30,000	New	+$3.23M	0.07%	147
2020 Q4	–	Sell	-31,440	Closed	-$2.49M	–	212
2020 Q3	$2.49M	Sell	31,440 -27,772	-47%	-$2.18M	0.05%	144
2020 Q2	$4.37M	Buy	59,212 +6,812	+13%	+$513K	0.1%	119
2020 Q1	$3.85M	Buy	+52,400	New	+$4.12M	0.08%	146
2018 Q4	–	Sell	-47,289	Closed	-$3.2M	–	300
2018 Q3	$3.2M	Sell	47,289 -121,439	-72%	-$7.74M	0.07%	155
2018 Q2	$9.77M	Buy	168,728 +52,400	+45%	+$2.96M	0.21%	129
2018 Q1	$6.05M	Buy	116,328 +31,440	+37%	+$1.7M	0.12%	156
2017 Q4	$4.56M	Hold	84,888	–	–	0.09%	144
2017 Q3	$5.19M	Buy	84,888 +20,960	+33%	+$1.27M	0.1%	146
2017 Q2	$3.91M	Sell	63,928 -4,192	-6%	-$255K	0.07%	159
2017 Q1	$4.13M	Hold	68,120	–	–	0.08%	159
2016 Q4	$3.83M	Buy	+68,120	New	+$3.99M	0.07%	162

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advent Capital Management's MRK Position: Q1 2025 in Review

Advent Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 25,000 shares — an estimated $2.49M sold.

Advent Capital Management first reported a position in MRK in Q4 2016 and held it in 14 quarters. The position peaked at $9.77M in Q2 2018. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Advent Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Advent Capital Management sold 25,000 Merck shares in Q1 2025, an estimated $2.49M.
Advent Capital Management first reported a position in Merck in Q4 2016 and held it in 14 quarters.
Advent Capital Management's Merck position peaked at $9.77M in Q2 2018.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Advent Capital Management's 13F filing for Q1 2025, filed 12 May 2025.